Company Northwest Biotherapeutics, Inc OTC Bulletin Board
Equities
US66737P5017
Biotechnology & Medical Research
End-of-day quote
Other stock markets
|
||
- USD | - |
May. 10 | Northwest Biotherapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Mar. 21 | Northwest Biotherapeutics, Inc. Appoints Pat Sarma to Its Board of Directors | CI |
Business Summary
Sales per Business
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Innovative Immunotherapies for Cancer
100.0
%
| 2 | 100.0 % | 2 | 100.0 % | +14.80% |
Sales per region
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
United States, Germany, United Kingdom and Netherlands
100.0
%
| 2 | 100.0 % | 2 | 100.0 % | +14.80% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Linda Powers
CEO | Chief Executive Officer | 68 | 07-05-16 |
Alton Boynton
FOU | Founder | 79 | 96-03-17 |
Marnix Bosch
CTO | Chief Tech/Sci/R&D Officer | 65 | 99-12-31 |
David Innes
IRC | Investor Relations Contact | - | 19-02-25 |
Leslie Goldman
LAW | General Counsel | 78 | 11-05-31 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Alton Boynton
FOU | Founder | 79 | 96-03-17 |
Linda Powers
CEO | Chief Executive Officer | 68 | 07-05-16 |
Navid Malik
BRD | Director/Board Member | 55 | 12-03-31 |
Joseph Black
BRD | Director/Board Member | 74 | 16-01-26 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 0 | 1,300,000 | 0 | 0 | 90.82 % |
Stock B | 1 | 1,208,177,416 | 1,097,287,981 ( 90.82 %) | 0 |
Company contact information
Northwest Biotherapeutics, Inc.
4800 Montgomery Lane Suite 800
20814, Bethesda
+240 497 9024
http://www.nwbio.comSector
1st Jan change | Capi. | |
---|---|---|
+11.91% | 118B | |
+11.60% | 106B | |
-4.68% | 24.28B | |
-0.82% | 21.96B | |
-10.12% | 18.16B | |
-42.12% | 16.37B | |
-17.47% | 15.56B | |
+2.77% | 13.63B | |
+34.58% | 12.27B |
- Stock Market
- Equities
- NWBO Stock
- Stock
- Company Northwest Biotherapeutics, Inc